Beta Receptor Blockade Potentiates the Antiarrhythmic Actions of d-Sotalol on Reentrant Ventricular Tachycardia in a Canine Model of Myocardial Infarction

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 11, 2003, Pages 1233-1244

  Kassotis, John ^a   Sauberman, Roy B ^a   Cabo, Candido ^b   Wit, Andrew L ^b   Coromilas, James ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Beta receptor blockade; Potassium channel block; Reentry; Ventricular tachycardia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SOTALOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOLERABILITY; ELECTROGRAPHY; EPICARDIUM; EXPERIMENTAL ANIMAL; FRACTIONATION; GAP JUNCTION; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; LEFT CORONARY ARTERY; LOW DRUG DOSE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; REENTRY TACHYCARDIA; REFRACTORY PERIOD; TACHYCARDIA;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOGS; DRUG SYNERGISM; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; MYOCARDIAL INFARCTION; PROPANOLAMINES; SOTALOL; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0344010963     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.02413.x     Document Type: Article

References (45)

1. Mason JW: A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458.
2. Kuhlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L: Suppression of sustained ventricular tachyarrhythmias: A comparison of d,1 sotalol with no antiarrhythmic treatment. J Am Coll Cardiol 1999;33:46-52.
3. Vaughan-Williams EM: Classifying antiarrhythmic actions by facts or speculation. J Clin Pharmacol 1992;32:964-977.
4. Hohnloser SH, Woosley RL: Sotalol. N Engl J Med 1994;331:31-38.
5. Advani SV, Sikngh BN: Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol. Drugs 1995;49:664-679.
6. Waldo A, Camm JA, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP for the SWORD Investigators: Effects of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12.
7. Reiffel JA, Hahn E, Reiter MJ: Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions and relative efficacy versus class I drugs after prior drug failure. ESVEM investigators. Electrophysiologic study versus electrocardiographic monitoring. Am J Cardiol 1997;79:1048-1053.
8. Mani V, Wu X, Wood MA, Ellenbogen KA, Hsia PW: Variation of spectral power immediately prior to spontaneous onset of ventricular tachycardia/ ventricular fibrillation in implantable cardioverter defibrillator patients. J Cardiovasc Electrophysiol 1999;10:1586-1596.
9. Reilly CS, Wood M, Koshakji RP, Wood AJJ: Ultrashort-acting beta-blockade: A comparison with conventional beta-blockade. Clin Pharmacol Ther 1985;38:579-585.
10. Dillon SM, Allessie MA, Ursell PC, Wit AL: Influence of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res 1988;63:182-206.
11. Kassotis J, Sauberman RB, Ciaccio EJ, Wit AL, Coromilas J: Mechanism of efficacy of the combination of d-sotalol and esmolol in the prevention of sustained ventricular tachycardia. Pacing Clin Electrophysiol 19:617, 1996.
12. Coromilas J, Saltman AE, Waldecker B, Dillon SM, Wit AL: Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts. Circulation 1995;91:2245-2263.
13. Costeas C, Peters NS, Waldecker B, Wit AL, Coromilas J: Mechanisms causing sustained ventricular tachycardia with multiple QRS morphologies: results of mapping studies in the infarcted canine heart. Circulation 1997;96:3721-3731.
14. Funk-Brentano C, Silberstein DJ, Roden DM, Wood AJ, Woosley RI: A mechanism of D-(+)sotalol effects on heart rate not related to beta-adrenoreceptor antagonism. Br J Clin Pharmacol 1990;30:195-202.
15. Cobbe SM, Hoffman E, Ritzenhoff A, Brachman J, Kubler W, Senges J: Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase. Circulation 1983;68:865-871.
16. Karagueuzian HS, Fenoglio JJ Jr, Weiss MB, Wit AL: Protracted ventricular tachycardia induced by premature stimulation of the canine heart after coronary artery occlusion and reperfusion. Circ Res 1979;44:833-845.
17. Butrous GS, Gough WB, Restivo M, Yang Y, El-Sherif N: Adrenergic effects on reentrant ventricular rhythms in subacute myocardial infarction. Circulation 1992;86:247-254.
18. Haws CW, Lux RL: Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms: Effect of interventions that alter repolarization time. Circulation.
19. Zuanetti G, Hoyt RH, Corr PB: Beta adrenergic mediated influences on microscopic conduction in epicardial regions overlying infarcted myocardium. Circ Res 1990;67:284-302.
20. Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, von Leitner ER: A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular arrhythmias. N Engl J Med 1992;327:987-992.
21. Yusuf S, Petro R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
22. Freigang KD, Becker R, Senges JC, Kraft P, Brachmann J, Kubler W, Schoels W: Differential effects of d-sotalol on normal and infarcted myocardium: An experimental study using epicardial mapping. Cardiovasc Res 1997;35:52-59.
23. Lynch JJ, Coskey LA, Montgomery DG, Lucchesi BR: Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. Am Heart J 1985;109:949-958.
24. Chen JG, Xue YX, Eto K, Ni C, Hashimoto K: Effects of dofetilide, a class III antiarrhythmic drug on various ventricular arrhythmias in dogs. J Cardiovasc Pharmacol 1996;28:576-584.
25. Katoh H, Ogawa S, Furuno I, Sato Y, Yoh S, Saeki K, Nakamura Y: Electrophysiologic effects of E-4031, a class III antiarrhythmic agent on reentrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model. J Pharmacol Exp Ther 1990;253:1077-1082.
26. Zuanetti G, Corr PB: Antiarrhythmic efficacy of a new class III agent, UK-68,798 during chronic myocardial infarction: Evaluation using three-dimensional mapping. J Pharmacol Exptl Ther 1991;256:325-334.
27. Coromilas J, Saltman AE, Wit AL: Effect of class III antiarrhythmic drugs on anisotropic reentry in canine infarcts. Circulation 1990;82(Suppl III):III-453.
28. Salazar DE, Much DR, Nicholas PS, Seibold JR, Shindler D, Slugg PH: A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects. J Clin Pharmacol 1997;37:799-809.
29. Peters NS, Coromilas J, Hanna MS, Josephson ME, Costeas C, Wit AL: Characteristics of the temporal and spatial excitable gap in anisotropic reentrant circuits causing sustained ventricular tachycardia. Circ Res 1998;82:279-293.
30. Fei H, Frame LH: d-Sotalol terminates reentry by two mechanisms with different dependence on the duration of the excitable gap. J Pharmacol Exp Ther 1996;277:174-185.
31. Boersma L, Brugada J, Abdollah H, Kirchof C, Allessie M: Effects of heptanol, class 1C and class III drugs on reentrant ventricular tachycardia. Importance of the excitable gap for the inducibility of double-wave reentry. Circulation 1994;90:1012-1022.
32. Brachmann J, Schols W, Beyer T, Montero M, Enders B, Kubler W: Acute and chronic antiarrhythmic effects of d-sotalol in patients with sustained ventricular tachyarrhythmias. Eur Heart J 1993;14(Suppl II):85-87.
33. Hohnloser SH, Meinertz T, Stubbs P, Crijns HF, Blanc JJ, Rizzon P, Cheuvart B: Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC study group. Circulation 1995;92:1517-1525.
34. Gardner PI, Ursell PC, Fenoglio JJ Jr, Wit AL: Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985;72:596-611.
35. Sanguinetti MC, Jurkiewicz NK: Two components of cardiac delayed rectifier K current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
36. ks) in canine ventricular epicardial, mid-myocardial and endocardial myocytes. Circ Res 1995;76:351-365.
37. Li GR, Feng JL, Yue LX, Carrier M, Nattel S: Evidence for two components of delayed rectifier K current in human ventricular myocytes. Circ Res 1996;78:689-696.
38. Huikuri HV, Yli-Mayry S: Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle. Pacing Clin Electrophysiol 1992;5:2103-2107.
39. Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PK: Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circ Res 1991;68:77-84.
40. kr blockade: Implications for the antifibrillatory efficacy of potassium channel blocking agents. J Am Coll Cardiol 1995;25:1609-1614.
41. Sager PT, Behboodikhah M: Frequency-dependent electrophysiologic effects of d,1-sotalol and quinidine and modulation by beta-adrenergic stimulation. J Cardiovasc Electrophysiol 1996;7:102-112.
42. Jazayeri MR, Van Wyhe G, Avitall B, McKinnie J, Tchou P, Akhtar M: Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1989;14:705-711.
43. Groh WJ, Gibson KJ, McAnulty JH, Maylie JG. β-adrenergic blocking property of d1-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol. Circulation 1995;91:262-264.
44. DeMello WC: Effect of isoproterenol and 3-isobutyl-1-methylxanthine on junctional conductance in heart cell pairs. Biochim Biophys Acta 1988;1012:291-298.
45. Freedman RA, Karagounis LA, Steinberg JS: Effect of sotalol on the signal-averaged electrocardiogram in patients with sustained ventricular tachycardia. Relation to suppression of inducibility and changes in tachycardia cycle length. J Am Coll Cardiol 1992;20:1213-1219.